Ixico PLC | Ownership

Companies that own Ixico PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Asset Management Ltd.
6,205,222
13.27%
0
0%
05/30/2018
Amati Global Investors Ltd.
5,031,370
10.76%
5,031,370
1.21%
05/30/2018
Henderson Global Investors Ltd.
934,000
2%
934,000
0%
08/01/2018
Charles Stanley & Co. Ltd. (Investment Management)
373,000
0.8%
0
0.02%
08/01/2018
Hargreaves Lansdown Stockbrokers Ltd.
302,000
0.65%
7,000
0%
08/01/2018
Hargreaves Lansdown Asset Management Ltd.
266,000
0.56%
57,000
0%
08/01/2018
Sanlam Investment Management (Pty) Ltd.
200,000
0.43%
196,000
0%
08/01/2018
Jarvis Investment Management Ltd.
135,000
0.28%
0
0%
08/01/2018
HSBC Global Asset Management (UK) Ltd.
88,000
0.19%
1,000
0%
08/01/2018
AXA Investment Managers UK Ltd.
37,000
0.08%
37,000
0%
08/01/2018

About Ixico

View Profile
Address
Griffin Court
London Greater London EC1A 9PN
United Kingdom
Employees -
Website http://ixico.com/
Updated 07/08/2019
IXICO Plc engages in the provision of technology-enabled specialty services to the global biopharmaceutical industry. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was founded by Derek Lionel Glendon Hill on November 28, 1995 and is headquartered in London, the United Kingdom.